EPO Patents = 1

Trademarks = 4

Forward Citations = 7

Loading Chart...

4 inventors (with patents filed for the assignee):

Mari Dezawa (7 out of 28 patents)

Masanori Yoshida (7 out of 11 patents)

Yoshinori Fujiyoshi (3 out of 9 patents)

4. Shinya Minatoguchi (3 out of 3 patents)

7 patents: Sort by Forward Citations

1. 10639335 - Pluripotent stem cell that induces repair and regeneration after myocardial infarction (2020-05-05),

2. 10376544 - Pluripotent stem cell that induces repair and regeneration after myocardial infarction (2019-08-13),

3. 10369162 - Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage (2019-08-06),

4. 10293003 - Multilineage-differentiating stress enduring (MUSE) cells for treatment of chronic kidney disease (2019-05-21),

5. 10034889 - Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage (2018-07-31),

6. 9844570 - Pluripotent stem cell that induces repair and regeneration after myocardial infarction (2017-12-19),

7. 9446033 - Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury (2016-09-20),

Company Overview

Clio, Inc. is a leading provider of cloud-based legal technology solutions for law firms. Our flagship product, Clio Manage, helps lawyers streamline their practice management processes and improve client communication. With features such as time tracking, billing, and document management, Clio allows legal professionals to focus on what they do best: serving their clients. Visit our website to learn more about how Clio can transform your firm.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#9 in Akita 016-0892

#5,459 in Japan

Akita, Japan

Clio, Inc.

Forward Citations = 7

4 inventors:

Mari Dezawa (7 out of 28 patents)

Masanori Yoshida (7 out of 11 patents)

Yoshinori Fujiyoshi (3 out of 9 patents)

4. Shinya Minatoguchi (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Clio, Inc.. Retrieved from https://idiyas.com/company/clio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]